STATEMENT OF CHANGES IN STOCKHOLDERS' EQUITY - 4 months ended Dec. 31, 2021 - USD ($)	Common Stock Sponsor	Common Stock Representative	Common Stock	Additional Paid-in Capital Sponsor	Additional Paid-in Capital Representative	Additional Paid-in Capital	Accumulated Deficit	Sponsor	Representative	Total
Balance at the beginning at Sep. 01, 2021			$ 0			$ 0	$ 0			$ 0
Balance at the beginning (in shares) at Sep. 01, 2021			0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock	$ 517	$ 18		$ 24,483	$ 897			$ 25,000	$ 915
Issuance of common stock (in shares)	5,175,000	180,000
Sale of 715,000 Private Placement Units			$ 80			7,959,920				7,960,000
Sale of 715,000 Private Placement Units (in shares)			796,000
Proceeds allocated to Public Rights						17,595,000				17,595,000
Accretion of Common stock subject to redemption						(24,217,520)				(24,217,520)
Net loss							(235,380)			(235,380)
Balance at the end at Dec. 31, 2021			$ 615			$ 1,362,780	$ (235,380)			$ 1,128,015
Balance at the end (in shares) at Dec. 31, 2021			6,151,000